Madison Avenue Partners, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $626 Million distributed in 15 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Graham Holdings CO with a value of $205M, John Wiley & Sons, Inc. with a value of $92M, Theravance Biopharma, Inc. with a value of $89.5M, Acadia Healthcare Company, Inc. with a value of $76.3M, and Endeavor Group Holdings, Inc. with a value of $75M.
Examining the 13F form we can see an decrease of $186M in the current position value, from $812M to 626M.
Madison Avenue Partners, LP is based out at New York, NY
Below you can find more details about Madison Avenue Partners, LP portfolio as well as his latest detailed transactions.